The report “Continuous Manufacturing Market Product (Integrated system, Semi-continuous (Granulator, Coater, Blender), Control), Application (API, End Product (Solid Dosage)), End User (R&D Department (CRO), Pharmaceutical Companies, CMO) – Global Forecast to 2022″, report provides a detailed overview of the major drivers, restraints, opportunities, and threat impacting the continuous manufacturing market along with the estimates and forecasts of the revenue and market share analysis.
Browse 162 market data tables and 52 figures spread through 181 pages and in-depth TOC on “Continuous Manufacturing Market – Global Forecast to 2022”
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=84747779
The global continuous manufacturing market is expected to reach USD 650.4 Million by 2022 from USD 348.5 Million in 2017, at a CAGR of 13.3%. Growth in this market can be attributed to the advantages of continuous manufacturing in pharmaceutical processes such as cost-effectiveness and improved efficiency of manufacturing. In addition, the favorable regulatory environment is expected to drive the adoption of continuous manufacturing processes in the pharmaceutical industry.
The market is segmented on the basis of product, application, end user, and region. On the basis of product, the market is segmented into integrated systems, semi-continuous systems, and controls. The integrated systems segment is expected to account for the largest share of the market in 2017. Integrated systems enable end-to-end manufacturing to convert raw materials into final products. In addition, these systems save substantial cost and time by integrating various pharmaceutical processes in a single system.
On the basis of application, the market is broadly classified into active pharmaceutical ingredient (API) manufacturing and end product manufacturing. The end product manufacturing segment is further categorized as solid dosage manufacturing and liquid dosage manufacturing. The end product manufacturing segment is estimated to account for the largest share of the market in 2017. The increased usage of continuous manufacturing techniques for end product manufacturing is the primary factor driving the growth of this application segment.
On the basis of end user, the market is segmented into R&D departments and full-scale manufacturing companies. The full-scale manufacturing companies segment includes pharmaceutical companies and contract manufacturing organizations (CMOs). The full-scale manufacturing companies segment is expected to dominate this market in 2017. The large share of this segment can be attributed to the increasing adoption of continuous technologies by pharmaceutical manufacturing companies and CMOs to address the challenges related to product quality, drug supply, and operational costs.
Get a PDF Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=84747779
On the basis of geography, the market is segmented into North America, Europe, Asia-Pacific, and RoW (Rest of the World). Of these, the North American segment is expected to account the largest share of the market in 2017. The support from regulatory bodies, initiation by leading pharmaceutical companies, and the need for pharmaceutical manufacturers to reduce rising operational costs and eliminate issues related to the inconsistent quality of pharmaceutical products produced through batch manufacturing are the factors driving the growth of this market in this region.
The prominent players in the market are GEA Group AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Bosch Packaging Technology (Germany), Coperion GmbH (Germany), and Glatt GmbH (Germany).
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
Continuous Manufacturing Market
US EVERY YEAR FOR THEIR
HOME ❯ TOP MARKET REPORTS ❯ CONTINUOUS MANUFACTURING MARKET
Continuous Manufacturing Market By Product (Integrated system,
Semi-continuous (Granulator, Coater, Blender), Control), Application
(API, End Product (Solid Dosage)), End User (R&D Department (CRO),
Pharmaceutical Companies, CMO) - Global Forecast to 2022
[181 Pages Report] The global continuous manufacturing market is expected to reach USD 650.4
Million by 2022 from USD 348.5 Million in 2017, at a CAGR of 13.3%. The major drivers for the
market include advantages of continuous manufacturing in pharmaceutical processes such as cost-
effectiveness and improved efficiency of manufacturing, favorable regulatory environment, and
support from regulatory authorities for the implementation of continuous manufacturing.
The report provides an overall understanding of the Continuous Manufacturing Market. In this
report, the market is segmented on the basis of product, application, end user, and geography. The
product segment includes integrated systems, semi-continuous systems, and controls. Among these
product segments, the integrated systems segment is expected to account for the largest share of
the Continuous Manufacturing market in 2017. The application segment includes Active
Pharmaceutical Ingredient (API) manufacturing and end product manufacturing. The end user
segment includes R&D departments and full-scale manufacturing companies. The geographic
segments included in this report are North America, Europe, Asia-Pacific, and the Rest of the World
A combination of bottom-up and top-down approaches was used to calculate the Continuous
Manufacturing market sizes and growth rates of the market and its subsegments. All percentage
shares, splits, and breakdowns were determined using secondary sources and verified through
primary sources. All possible parameters that affect